Invention Grant
- Patent Title: Azaphenalene-3-one derivative, preparation method therefor, and application therof
-
Application No.: US16497773Application Date: 2018-05-24
-
Publication No.: US10669274B2Publication Date: 2020-06-02
- Inventor: Hao Zhang , Xiaodong Wang , Weiliang Xu , Weizheng Xu
- Applicant: SUZHOU KANGRUN PHARMACEUTICALS INC.
- Applicant Address: CN Suzhou
- Assignee: SUZHOU KANGRUN PHARMACEUTICALS INC.
- Current Assignee: SUZHOU KANGRUN PHARMACEUTICALS INC.
- Current Assignee Address: CN Suzhou
- Agency: SZDC Law P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@25646670
- International Application: PCT/CN2018/088201 WO 20180524
- International Announcement: WO2018/177444 WO 20181004
- Main IPC: C07D471/16
- IPC: C07D471/16

Abstract:
Disclosed are an azaphenalene-3-one derivative, its preparation method and its application, in the field of pharmaceutical synthesis. The derivative has the following Formula (I), wherein R is H, 2-fluoroethylamino, 2,2,2-trifluoroethylamino, diethylamino, pyrrolidinyl, imidazolyl, piperidinyl, morphinolinyl, 4-methylaminopiperidinyl, 4-dimethylaminopiperidinyl, (1-methylpiperidin-4-yl)methylamino, (1-phenylpiperidin-4-yl)methylamino, (1-benzylpiperidin-4-yl)methylamino, or 7-fluoro-3,4-dihydroisoquinoline-2(1H)-yl. The preparation method of the azaphenalene-3-one derivative is simple, the yield is high, post-treatment is easy, and purity is high. The derivative has high inhibitory activity against PARP enzyme. It establishes a foundation for researching better anti-tumor drugs using PARP inhibitors.
Public/Granted literature
- US20200031828A1 AZAPHENALENE-3-ONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEROF Public/Granted day:2020-01-30
Information query